Investigation of reperfusion injury and ischemic preconditioning in microsurgery

Microsurgery

Volumn 29, Issue 1, 2009, Pages 72-79

  Wang, Wei Zhong ^a  

^a UNIVERSITY OF NEVADA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; GLYCOLYSIS; HUMAN; ISCHEMIC PRECONDITIONING; MICROCIRCULATION; MICROSURGERY; MICROVASCULATURE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; TISSUE PERFUSION;

ANIMALS; ENDOTHELIUM, VASCULAR; HUMANS; ISCHEMIA; ISCHEMIC PRECONDITIONING; MICROCIRCULATION; MICROSURGERY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REPERFUSION; REPERFUSION INJURY; TREATMENT OUTCOME;

EID: 58849101394     PISSN: 07381085     EISSN: 10982752     Source Type: Journal    
DOI: 10.1002/micr.20587     Document Type: Review

References (101)

1. Chen CW, Chien YC, Pao YS. Salvage of the forearm following complete traumatic amputation: Report of a successful case. Chin Med J 1963;82:633-638.
2. Malt RA, McKhann C. Replantation of severed arms. JAMA 1994;198:716.
3. Macleod AM, Morrison WA, O'Brien BM. Replantation surgery in the upper extremity. In: Jupiter JB, editor. Flynn's Hand Surgery, 4th ed. Baltimore: Williams & Wilkins; 1991. pp 563-573.
4. Carden DL, Granger DN. Pathophysiology of ischemia-reperfusion injury. J Pathol 2000;190:255-266.
5. Granger DN. Ischemia-reperfusion: Mechanism of microvascular dysfunction and the influence of risk factors for cardiovascular disease. Microcirculaion 1999;6:167-178.
6. Strock PE, Majno G. Microvascular changes in experimental tourniquet ischemia. Surg Gynecol Obstet 1969;129:1213-1224.
7. Quinones-Baldrich WJ, Chervu A, Hernandez JJ, Colburn M, Moore WS. Skeletal muscle function after ischemia: ''No reflow'' verse reperfusion injury. J Surg Res 1991;51:5-12.
8. Korthuis RJ, Granger DN, Townsley MI, Taylor AE. The role of oxygen derived free radicals in ischemia induced increases in canine skeletal muscle in postischemic skeletal muscle vascular permeability. Circ Res 1985;57:599-609.
9. VanBenthuysen KM, McMurtry IF, Horwitz LD. Reperfusion after acute coronary occlusion in dog impairs endothelium-dependent relaxation to acetylcholine and augments contractile reactivity in vitro. J Clin Invest 1987;79:265-274.
10. Davies MG, Hagen PO. The vascular endothelium. A new horizon. Ann Surg 1993;218:593-609.
11. Munzel T, Afanasev IB, Kleschyov AL, Harrison DG. Detecion of superoxide in vascular tissue. Arterioscler Thromb Vasc Biol 2002;22:1761-1768.
12. Frangogiannis NG, Youker KA, Rossen RD, Gwechenberger M, Lindsey MH, Mendoza LH, Michael LH, Ballantyne CM, Smith CW, Entman ML. Cytokines and the microcirculation in ischemia and reperfusion. J Mol Cell Cardiol 1998;30:2567-2576.
13. Honda HM, Korge P, Weiss JN. Mitochondria and ischemia/reper-fusion injury. Ann N Y Acad Sci 2005;1047:248-258.
14. Halestrap AP. The mitochondrial permeability transition: Its molecular mechanism and role in reperfusion injury. Biochem Soc Symp 1999;66:181 - 203.
15. Halestrap AP, Clarke SJ, Javadov SA. Mitochondrial permeability transition pore opening during myocardial reperfusion-A target for cardioprotection. Cardiovasc Res 2004;61:372-385.
16. Weiss JN, Korge P, Honda HM, Ping P. Role of the mitochondrial permeability transition in myocardial disease. Circ Res 2003;93: 292-301.
17. Hausenloy DJ, Yellon DM. The mitochondrial permeability transition pore: Its fundamental role in mediating cell death during ischaemia and reperfusion. J Mol Cell Cardiol 2003;35:339-341.
18. Kin JS, He L, Lemasters JJ. Mitochondrial permeability transition: A common pathway to necrosis and apoptosis. Biochem Biophys Res Commun 2003;304:463-470.
19. Downey JM, Cohen MV. We think we see a pattern emerging here. Circulation 2005;111:120-121.
20. Buncke HJ, Jackson RL. Buncke GM. The surgical and rehabilitative aspects of replanation and revascularization of the hand. In: Hunter JM, Mackin EJ, Callahan AD, editors. Rehabilitation of the Hand: Surgery and Therapy, 4th ed., Vol. II. St. Louis: Mosby; 1995. pp 1075-1083.
21. 21.Tsao PS, Lefter AM. Time course and mechanism of endothelial dysfunction in isolated ischemic-and hypoxic-perfused rat hearts. Am J Physiol 1990;259:H1660-H1666.
22. Sanders WE. Principles of microvascular surgery. In: Green DP, editor. Operative Hand Surgery, 3rd ed., Vol. I. New York: Churchill Livingstone; 1993. p 1039.
23. Suominen S, Asko-Seljavaara S. Free flap failures. Microsurgery 1995;16:396-399.
24. Ahmad TS, Musa G, Lee JK. A review of free flap failures in the University Hospital, Kuala Lumpur. Ann Acad Med Singapore 1997;26:840-843.
25. Wang WZ, Anderson GL, Firrell JC. Arteriole constriction following ischemia in denervated skeletal muscle. J Reconstr Microsurg 1995;11:99-106.
26. Wang WZ, Anderson GL, Maldonado C, Barker J. Attenuation of vasospasm and capillary no-reflow by ischemic preconditioning in skeletal muscle. Microsurgery 1996;17:324-329.
27. Wang WZ, Anderson G, Fleming JT, Peter FW, Franken RJ, Acland RD, Barker J. Lack of nitric oxide contributes to vasospasm during ischemia reperfusion injury. Plast Reconstr Surg 1997;99: 1099-1108.
28. Wang WZ, Anderson GL, Firrell JC, Tsai TM. Ischemic preconditioning versus intermittent reperfusion to improve blood flow to a vascular isolated skeletal muscle flap of rats. J Trauma 1998;45: 953-959.
29. Wang WZ, Tsai TM, Anderson GL. Late preconditioning protection is evident in the microcirculation of denervated skeletal muscle. J Orthop Res 1999;17:571-579.
30. Wang WZ, Guo SZ, Tsai TM, Anderson GL, Miller FN. The initiation of microvascular protection by nitric oxide in the late preconditioning. J Reconstr Microsurg 2000;16:621-628.
31. Wang WZ, Guo SZ, Tsai TM, Anderson GL, Miller FN. The initiating factors of late preconditioning in the microcirculation of skeletal muscle. J Surg Res 2001;99:92-99.
32. Lee YH, Wei FC, Lee J, Su MS, Chang YC. Effect of postischemic reperfusion on microcirculation and lipid metabolism of skeletal muscle. Microsurgery 1995;16:522-527.
33. Gavin J, Haunso S. Introduction to the focused issue. The microcir-culation as a foundation of cardiovascular disease. J Mol Cell Car-diol 1998;30:2529-2530.
34. Schiffrin EL. The endothelium and control of blood vessel function in health and disease. Clin Invest Med 1994;17:602-620.
35. Menger MD, Rucker M, Vollmar B. Capillary dysfunction in striated muscle ischemia/reperfusion: On the mechanisma of capillary ''no-reflow.'' Shock 1997;8:2-7.
36. Lefer AM, Lefer DJ. The role of nitric oxide and cell adhesion molecules on the microcirculation in ischemia-reperfusion. Cardio-vasc Res 1996;32:743-751.
37. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980;299:373-376.
38. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial cell injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 1990;87:1620-1624.
39. Hallstrom S, Gasser H, Neumayer C, Fugl A, Nanobashvili J, Jaku-bowski A, Huk I, Schlag G, Malinski T. S-nitroso human serum albumin treatment reduces ischemia/reperfusion injury in skeletal muscle via nitric oxide release. Circulation 2002;105:3032-3038.
40. Lepore DA, Kozlov AV, Stewart AG, Hurley JV, Morrison WA, Tomasi A. Nitric oxide synthase-independent generation of nitric oxide in rat skeletal muscle ischemia-reperfusion injury. Nitric Oxide 1999;3:75-84.
41. Blebea J, Bacik B, Strothman G, Myatt L. Decreased nitric oxide production following extremity ischemia and reperfusion. Am J Surg 1996;172:158-161.
42. Messina A, Knight KR, Dowsing BJ, Zhang B, Phan LH, Hurley JV, Morrison WA, Stewart AG. Localization of inducible nitric oxide synthase to mast cells during ischemia/reperfusion injury of skeletal muscle. Lab Invest 2000;80:423-431.
43. Wang WZ, Fang XH, Stephenson LL, Khiabani KT, Zamboni WA. Melatonin reduces I/R-induced superoxide generation in arterial wall and cell death in skeletal muscle. J Pineal Res 2006;41:255-260.
44. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium. Circulation 1986;74:1124-1136.
45. Shiki K, Hearse DJ. Preconditioning of ischemic myocardium: Reperfusion-induced arrhythmias. Am J Physiol 1987;253(6 Pt 2): H1470-H1476.
46. Schott RJ, Rohmann S, Braun ER, Schaper W. Ischemic preconditioning reduces infarct size in swine myocardium. Circ Res 1990;66:1133-1142.
47. Li GC, Vasquez JA, Gallagher KP, Lucchesi BR. Myocardial protection with preconditioning. Circulation 1990;82:609-619.
48. Peralta C, Hotter G, Closa D, Gelpi, Bulbena O, Rosello-Catafau J. Protective effect of preconditioning on the injury associated to hepatic ischemia-reperfusion in the rat: Role of nitric oxide and aden-osine. Hepatology 1997;25:934-937.
49. Li G, Chen S, Lu E, Hu T. Protective effects of ischemic preconditioning on lung ischemia reperfusion injury: An in-vivo rabbit study. Thorac Cardiovasc Surg 1999;47:38-41.
50. Mounsey RA, Pang CY, Forrest C. Preconditioning: A new technique for improved muscle flap survival. Otolaryngol Head Neck Surg 1992;107:549-552.
51. Zhang F, Oswald T, Holt J, Gerzenshtein J, Lei MP, Lineaweaver WC. Regulation of inducible nitric oxide synthase in ischemic preconditioning of muscle flap in a rat model. Ann Plast Surg 2004;52:609-613.
52. Bushell AJ, Klenerman L, Taylor S, Davies H, Grierson I, Helli-well TR, Jackson MJ. Ischaemic preconditioning of skeletal muscle. I. Protection against the structural changes induced by ischaemia/reperfusion injury. J Bone Joint Surg Br 2002;84:1184-1188.
53. Zahir KS, Syed SA, Zink JR, Restifo RJ, Thomson JG. Ischemic preconditioning improves the survival of skin and myocutaneous flaps in a rat model. Plast Reconstr Surg 1998;102:140-150.
54. Coskunfirat OK, Ozkan O, Dikici MB. The effect of ischemic preconditioning on secondary ischemia in skin flaps. Ann Plast Surg 2006;57:431-434.
55. Harder Y, Amon M, Schramm R, Georgi M, Banic A, Erni D, Menger MD. Heat shock preconditioning reduces ischemic tissue necrosis by heat shock protein (HSP)-32-mediated improvement of the microcirculation rather than induction of ischemic tolerance. Ann Surg 2005;242:869-878.
56. Bobek V, Sramek D, Rokyta R, Tvrdek M. Local pharmacological preconditioning increases the survival of experimental skin flaps in rats. Life Sci 2005;77:2663-2668.
57. Kiumehr S, Demehri S, Rabbani S, Amanpour S, Mohagheghi MA, Dehpour AR. Preconditioning of the rat random-pattern skin flap: Modulation by opioids. Br J Plast Surg 2005;58:58-64.
58. 58.Hosnuter M, Babuccu O, Kargi E, Altinyazar C. Dual preconditioning: Effects of pharmacological plus ischemic preconditioning on skin flap survival. Ann Plast Surg 2003;50:398-402.
59. Matsumura H, Yoshizawa N, Vedder NB, Watanabe K. Preconditioning of the distal portion of a rat random-pattern skin flap. Br J Plast Surg 2001;54:58-61.
60. Salmi AM, Hong C, Futrell JW. Preoperative cooling and warming of the donor site increase survival of skin flaps by the mechanism of ischemic preconditioning: An experimental study in rats. Scand J Plast Reconstr Surg Hand Surg 1999;33:163-167.
61. Rees RS, Smith DJ Jr, Adamson B, Im M, Hinshaw D. Oxidant stress: The role of the glutathione redox cycle in skin preconditioning. J Surg Res 1995;58:395-400.
62. 62.Wang H, Li Z, Liu X. Effects of various protocols of ischemic preconditioning on rat tram flaps. Microsurgery 2008;28:37-43.
63. Marber MS, Latchman DS, Walker JM, Yellon DM. Cardiac stress protein elevation 24 hours after brief ischemia or late stress is associated with resistance to myocardial infarction. Circulation 1993;88:1264-1472.
64. Kuzuya T, Hoshida S, Yamashita N, Fuji H, Oe H, Hori M, Kamada T, Tada M. Delayed effects of sublethal ischemia on the acquisition of telerance to ischemia. Circ Res 1993;72:1293-1299.
65. 65.Yellen DM, Downey JM. Preconditioning the myocardium: From cellular physiology to clinical cardiology. Physiol Rev 2003;83: 1131-1151.
66. 66.Das M, Das DK. Molecular mechanism of preconditioning. IUBMBLife 2008;60:199-203.
67. Bolli R. The late phase of preconditioning. Circ Res 2000;87: 972-983.
68. Wang WZ, Fang XH, Stephenson LL, Anderson GL, Miller FN, Khiabani KT, Zamboni WA. Role of PKC in microvascular protection induced by late preconditioning. J Surg Res 2002;106:166-172.
69. Wang WZ, Jones S, Stephenson LL, Khiabani KT, Zamboni WA.Microvascular protection induced by late preconditioning abolished in STZ-Induced diabetic rats. J Reconstr Microsurg 2002;18: 389-396.
70. Wang WZ, Fang XH, Stephenson LL, Khiabani KT, Zamboni WA. NOSs upregulation attenuates vascular endothelial dysfunction in the late phase of ischemic preconditioning in skeletal muscle. J Orthop Res 2004;22:578-585.
71. Zhao ZQ, Corvera JS, Halkos ME, Kerendi F, Wang NP, Guyton RA, Vinten-Johansen J. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: Comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol 2003;285:H579-H588.
72. Lucchesi BR. Myocardial reperfusion injury-role of free radicals and mediators of inflammation. In: Sperelakis N, Kurachi Y, Terzic A, Cohen MV, editors. Heart Physiology and Pathophysiology. San Diego, CA: Academic; 2001. pp 1181-1210.
73. Khanna A, Cowled PA, Fitridge RA. Nitric oxide and skeletal muscle reperfusion injury: Current controversies (research review). J Surg Res 2005;128:98-107.
74. McAllister SE, Ashrafpour H, Huang N, Cahoon NJ, Moses MA, Neligan PC, Forrest CR, Lipa JE, Pang CY. Postconditioning for salvage of ischemic skeletal muscle from reperfusion injury: Efficacy and mechanism. Am J Physiol Regul Integr Comp Physiol 2008;295:R681-R689.
75. Loukogeorgakis SP, Panagiotidou AT, Yellon DM, Deanfield JE, MacAllister RJ. Postconditioning protects against endothelial ische-mia-reperfusion injury in the human forearm. Circulation 2006;113: 1015-1019.
76. Moon JG, Lim HC, Gye MR, Oh JS, Park JW. Postconditioning attenuates ischemia-reperfusion injury in rat adipocutaneous flap. Microsurgery 2008;28:531-537.
77. Przyklenk K, Bauer B, Ovize M, Kloner RA, Whittaker P. Regional is-chemic preconditioning' protects remote virgin myocardium from subsequent sustained coronary occlusion. Circulation 1993;87:893-899.
78. Addison PD, Neligan PC, Ashrafpour H, Khan A, Zhong A, Moses M, Forrest CR, Pang CY. Noninvasive remote ischemic preconditioning for global protection of skeletal muscle against infarction. Am J Physiol Heart Circ Physiol 2003;285:H1435-H1443.
79. Schoemaker RG, van Heijningen CL. Bradykinin mediates cardiac preconditioning at a distance. Am J Physiol Heart Circ Physiol 2000;278:H1571-H1576.
80. Dickson EW, Lorbar M, Porcaro WA, Fenton RA, Reinhardt CP,Gysembergh A, Przyklenk K. Rabbit heart can be ''preconditioned'' via transfer of coronary effluent. Am J Physiol 1999;277:H2451-H2457.
81. Wang WZ, Fang XH, Stephenson LL, Khiabani KT, Zamboni WA. Ischemic preconditioning-induced microvascular protection at a distance. J Reconstr Microsurg 2004;20:61-67.
82. Chen YS, Chien CT, Ma MC, Tseng YZ, Lin FY, Wang SS, Chen CF. Protection ''outside the box'' (skeletal remote preconditioning) in rat model is triggered by free radical pathway. J Surg Res 2005;126:92-101.
83. Kuntscher MV, Kastell T, Engel H, Gebhard MM, Heitmann C, Ger-mann G. Late remote ischemic preconditioning in rat muscle and adi-pocutaneous flap models. Ann Plast Surg 2003;51:84-90.
84. Williamson JR, Kilo C, Tilton RG. Mechanisms of glucose- and diabetes-induced vascular dysfunction. In: Williamson JR, Ruderman N, Brownlee M, editors. Hyperglycemia, Diabetes and Vascular Disease. Oxford: Oxford University Press; 1992. pp 107-131.
85. Stehouwer CDA, Lambert J, Donker AJM, Hinsbergh VWM. Endo-thelial dysfunction and pathogenesis of diabetic angiopathy. Cardio-vasc Res 1997;34:55-68.
86. Tesfamariam B, Brown ML, Deykin D, Cohen R. Elevated glucose promotes generation of endothelium-derived vasoconstrictor prosta-noid in rabbit aorta. J Clin Invest 1990;85:929-932.
87. Meraji A, Jayakody L, Senaratne P, Thamson ABR, Harrison DG. Endothelium-dependent relaxation in aorta of BB rats. Diabetes 1987;36:878-881.
88. Oyama Y, Kawasaki H, Harttori Y, Kanno M. Attenuation of endo-thelium-dependent relaxation in aorta from diabetic rats. Eur J Pharmacol 1986;132:75-78.
89. Brothers TE, Robison JG, Elliott BM. Diabetes mellitus is the major risk factor for African Americans who undergo peripheral bypass graft operation. J Vasc Surg 1999;29:352-359.
90. Bouchard JF, Lamontagne D. Protection afforded by preconditioning to the diabetic heart against ischemic injury. Cardiovasc Res 1998;37:82-90.
91. Tatsumi T, Matoba S, Kobara M, Keira N, Kawahara A, Tsuruyama K, Tanaka T, Katamura M, Nakagawa C, Ohta B, Yamahara Y, Asayama J, Nakagawa M. Energy metabolism after ischemic preconditioning in streptozotocin-induced diabetic rat hearts. J Am Coll Cardiol 1998;31:707-715.
92. Tosaki A, Pali T, Lefaix D. Effects of Ginkgo biloba extract and preconditioning on the diabetic rat myocardium. Diabetologia 1996;39:1255-1262.
93. Kersten JR, Schmeling TJ, Orth KG, Pagel PS, Warltier DC. Acute hyperglycemia abolishes ischemic preconditioning in vivo. Am J Physiol Heart Circ Physiol 1998;275:H721-H725.
94. Hassouna A, Loubani M, Matata BM, Fowler A, Standen NB, Gali-nanes M. Mitochondrial dysfunction as the cause of the failure to precondition the diabetic human myocardium. Cardiovasc Res 2006;69:450-458.
95. Kristiansen SB, Lofgren B, Stottrup NB, Khatir D, Nielsen-Kudsk JE, Nielsen TT, Botker HE, Flyybjerg A. Ischaemic preconditioning does not protect the heart in obese and lean animal models of type 2 diabetes. Diabetologia 2004;47:1716-1721.
96. Del Valle HF, Lascano EC, Negroni JA, Corottogini AJ. Absence of ischemic preconditioning protection in diabetic sheep hearts: Role of sarcolemmal KATP channel dysfunction. Mol Cell Biochem 2003;249:21-30.
97. Deutsch E, Berger M, Kussmaul WG, Hirshfeld JW Jr, Herrmann HC, Laskey WK. Adaptation to ischemia during percutaneous trans-luminal coronary angioplasty: Clinical, hemodynamic, and metabolic features. Circulation 1990;82:2044-2051.
98. Yellon DM, Alkhulaifi AM, Pugsley WB. Preconditioning the human myocardium. Lancet 1993;342:276-277.
99. Jenkins DP, Pugsley WB, Alkhulaifi AM, Kemp M, Hooper J, Yellon DM. Ischaemic preconditioning reduces troponin T release in patients undergoing coronary artery bypass surgery. Heart 1997;77:314-318.
100. Clavien PA, Yadav S, Sindram D, Bentley RC. Protective effects of ischemic preconditioning for liver resection performed under inflow occlusion in humans. Ann Surg 2000;232:155-162.
101. Clavien PA, Selzner M, Rudiger HA, Graf R, Kadry Z, Rousson V, Jochum W. A prospective randomized study in 100 consecutive patients undergoing major liver resection with versus without ische-mic preconditioning. Ann Surg 2003;238:843-850.